These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 21146894)

  • 21. Assessment of pyrrolizidine alkaloid-induced toxicity in an in vitro screening model.
    Li YH; Kan WL; Li N; Lin G
    J Ethnopharmacol; 2013 Nov; 150(2):560-7. PubMed ID: 24045176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic veno-occlusive disease induced by Gymura segetum: report of two cases.
    Dai HF; Gao Y; Yang M; Yu CH; Gu ZY; Chen WX
    Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):406-8. PubMed ID: 16911940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic Toxification of 1,2-Unsaturated Pyrrolizidine Alkaloids Causes Human Hepatic Sinusoidal Obstruction Syndrome: The Update.
    Teschke R; Vongdala N; Quan NV; Quy TN; Xuan TD
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study.
    Liu F; Rong X; Guo H; Xu D; Liu C; Meng L; Yang X; Guo T; Kan X; Song Y
    BMC Gastroenterol; 2020 Feb; 20(1):30. PubMed ID: 32019495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seneciphylline, a main pyrrolizidine alkaloid in Gynura japonica, induces hepatotoxicity in mice and primary hepatocytes via activating mitochondria-mediated apoptosis.
    Wang W; Yang X; Chen Y; Ye X; Jiang K; Xiong A; Yang L; Wang Z
    J Appl Toxicol; 2020 Nov; 40(11):1534-1544. PubMed ID: 32618019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A TMT-based shotgun proteomics uncovers overexpression of thrombospondin 1 as a contributor in pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.
    Wang W; Chen Y; Yin Y; Wang X; Ye X; Jiang K; Zhang Y; Zhang J; Zhang W; Zhuge Y; Chen L; Peng C; Xiong A; Yang L; Wang Z
    Arch Toxicol; 2022 Jul; 96(7):2003-2019. PubMed ID: 35357534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gadoxetic Acid-Enhanced Hepatobiliary-Phase Magnetic Resonance Imaging for Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome and Association with Liver Function.
    Guo T; Li X; Yang X; Kong X; Liu H; Bai T; Xu K; Ye J; Song Y
    Sci Rep; 2019 Feb; 9(1):1231. PubMed ID: 30718698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticoagulant therapy likely increases risk of bleeding in Gynura segetum-induced hepatic sinus obstruction syndrome.
    Tan Y; Zhou X
    Medicine (Baltimore); 2024 Feb; 103(6):e35914. PubMed ID: 38335400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of Salvia miltiorrhiza in a mouse model of hepatic sinusoidal obstruction syndrome induced by Gynura segetum.
    Yang L; Huo JR; Zhu HY; Chen Z; Wang XY
    Rev Esp Enferm Dig; 2019 Nov; 111(11):823-827. PubMed ID: 31566407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urine and plasma metabolomics study on potential hepatoxic biomarkers identification in rats induced by Gynura segetum.
    Qiu S; Zhang H; Fei Q; Zhu F; Wang J; Jia X; Chen B
    J Ethnopharmacol; 2018 Apr; 216():37-46. PubMed ID: 29353003
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatic sinusoidal obstruction syndrome caused by herbal medicine: CT and MRI features.
    Zhou H; Wang YX; Lou HY; Xu XJ; Zhang MM
    Korean J Radiol; 2014; 15(2):218-25. PubMed ID: 24643319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous characterization of pyrrolizidine alkaloids and N-oxides in Gynura segetum by liquid chromatography/ion trap mass spectrometry.
    Qi X; Wu B; Cheng Y; Qu H
    Rapid Commun Mass Spectrom; 2009 Jan; 23(2):291-302. PubMed ID: 19072862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expert consensus on the clinical management of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.
    Zhuge Y; Liu Y; Xie W; Zou X; Xu J; Wang J;
    J Gastroenterol Hepatol; 2019 Apr; 34(4):634-642. PubMed ID: 30669184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bear bile powder attenuates senecionine-induced hepatic sinusoidal obstruction syndrome in mice.
    Jiang KY; Zhang Y; Ye XL; Xiong F; Chen Y; Jia XL; Zhang YX; Yang L; Xiong AZ; Wang ZT
    Chin J Nat Med; 2022 Apr; 20(4):270-281. PubMed ID: 35487597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pyrrole-protein adducts - A biomarker of pyrrolizidine alkaloid-induced hepatotoxicity.
    Ma J; Xia Q; Fu PP; Lin G
    J Food Drug Anal; 2018 Jul; 26(3):965-972. PubMed ID: 29976414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro metabolism of isoline, a pyrrolizidine alkaloid from Ligularia duciformis, by rodent liver microsomal esterase and enhanced hepatotoxicity by esterase inhibitors.
    Tang J; Akao T; Nakamura N; Wang ZT; Takagawa K; Sasahara M; Hattori M
    Drug Metab Dispos; 2007 Oct; 35(10):1832-9. PubMed ID: 17639025
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical analysis of hepatic veno-occlusive disease induced by Sedum aizoon].
    Wu GL; Yu GY; Chen J
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(20):2402-4. PubMed ID: 19157138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low molecular weight heparin in the treatment of pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome: five case reports.
    Jiang M; Wang L; Du X; Hao M; Gao P
    J Int Med Res; 2020 Sep; 48(9):300060520961916. PubMed ID: 32993424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pulmonary toxicity is a common phenomenon of toxic pyrrolizidine alkaloids.
    Song Z; He Y; Ma J; Fu PP; Lin G
    J Environ Sci Health C Toxicol Carcinog; 2020; 38(2):124-140. PubMed ID: 32500835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of toxic components in different medicinal parts of Gynura japonica and its toxicity assessment on mice.
    Xiong A; Shao Y; Fang L; Yang X; Zhang S; Zheng J; Ding W; Yang L; Wang Z
    Phytomedicine; 2019 Feb; 54():77-88. PubMed ID: 30668385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.